The ALS Challenge: More Than a Bucket of Ice

“Hi I’m Sally and I’m about to do the ALS Ice Bucket Challenge. I’m going to nominate my three friends Jimmy, Johnny, and Hank to do the challenge as well. Do the challenge and donate to a research center in your area. Good luck!”

I’m sure we are all very familiar with this type of post. It was all over social media in 2014. For a while it was almost like you couldn’t even go online without seeing these posts littering your timeline or page. “The ALS Ice Bucket Challenge was a tremendous event in our Association’s history, raising f$115 million in the summer of 2014. Not only did it bring awareness to this devastating disease, it importantly spurred a huge increase in our research budget.” This is what was said in a statement by the ALS Association. I agree with them that it raised lots of awareness about this devastating disease, but what I think was really lacking was a knowledge of what was really happening.

http://www.alsa.org/fight-als/ice-bucket-challenge.html

What is ALS?

ALS is a fatal motor neuron disease characterized by degeneration of upper and lower motor neurons. The symptoms of ALS are initially quite varied in people, with some people having trouble gripping things and others have sudden voice cracks. Eventually these symptoms can begin in the vocal muscles as well as in the hands, arms, legs, and feet. As it progresses, progressive muscle weakness and paralysis are experienced by all suffering from ALS. However, since ALS only attacks motor neurons, these people maintain their senses of sight, touch, feeling, taste, and smell, while being confined to their body being unable to move.

https://www.ncbi.nlm.nih.gov/pubmed/27150074
http://www.alsa.org/about-als/symptoms.html

What happens in ALS?

In individuals with ALS, there is some sort of oxidative damage caused by oxidative stress. This oxidative stress leads to damaged mitochondria, protein aggregation, and impaired autophagy. There is then a mutation in several proteins that bind RNA such as FUS and TDP43.

What are some treatments for ALS?

There are several treatments used for ALS, but it is ultimately lethal so these treatments are aimed at controlling symptoms, preventing unnecessary complications, and make living with the disease easier. These treatments are:

  • Medications:
    • Rilutek: decreases glutamate and reduces damage to motor neurons
    • Radicava: slows decline of daily functions
    • Pain medications, sleeping pills, and antidepressants
  • Physical therapy: prevent quick muscle deterioration
  • Speech therapy: computer-based speech synthesizers, eye-tracking technology
  • Nutritional support: feeding tubes, meal plans
  • Breathing support: respirators, oxygen masks, and breathing techniques

Much more research is needed to help improve these treatments so they target the source of the disease rather than just lessening of many of the symptoms caused by ALS.

Above are Stephen Hawking and Lou Gehrig, two of the most famous people to have suffered from ALS. There are approximately 30,000 Americans living with ALS in the United States today.

https://nypost.com/2016/05/21/whatever-happened-to-lou-gehrigs-bats/
https://usefulstoooges.com/2018/03/27/stephen-hawking-a-brilliant-scientist-a-flawed-man/

This brings me back to the Ice Bucket Challenge. I think in the future if there is some sort of foundation that is raising money by doing an event like this I would like to see it focus more on educating people of what is going on with the disease, giving money to research, and caring for those who have it, rather than just looking up funny videos of their friends trying out the challenge. This did a great job of bringing both awareness to the disease and money, but I feel like more attention was given to those who did the challenge. In the future hopefully we can both understand this disease better and ultimately treat or cure it.
http://www.alsa.org/news/media/quick-facts.html

ALS: the disease that takes the body, but not the mind

In the past eight months, two celebrities, Stephen Hawking, and Stephen Hillenburg, died from ALS, or what is more commonly known as Lou Gehrig’s disease. In 2014, social media was flooded with “Ice Bucket Challenge” videos which sought to raise money for ALS research. So what is ALS, and why is the average lifespan once diagnosed 2 to 5 years?

What is ALS?

ALS, stands for amyotrophic lateral sclerosis, and is a neurodegenerative disease that affects motor neurons found in the brain and spinal cord, and causes them to die. As the number of motor neurons decreases, the brain is no longer able to send messages to muscles, which leads to lack of muscle movement. This lack of movement causes muscle strength to weaken and muscle atrophy or muscle waste to occur. While ALS is devastating to the body, the mind of a person suffering from ALS remains sound.

The Two Types of ALS

ALS can come in two different forms, familial (fALS) and sporadic (sALS). fALS accounts for 10% of total ALS diagnoses. This type of ALS stems from inheritable, autosomal genetic mutations. Familial ALS is categorized as having another family member with ALS. Sporadic ALS makes up 90% of diagnoses. Patients with sALS have no family history of the disease. The average age of onset of sALS is 56, which is roughly ten years later than fALS which is 45. While these two sub-types of ALS do not differ clinically, their main underlying differences are if the patient has family history of ALS, and the development of genetic mutations.

In both fALS and sALS, there is a mutation of the SOD1 gene or Superoxide dismutase 1. SOD1 is an antioxidant enzyme that helps defend the body against ROS or Reactant Oxygen Species that cells produce. If there is a mutation to the SOD1 gene (as seen in ALS), oxidative stress occurs. This stress can cause what is known as unfolded protein aggregation which is found in motor neurons in people with ALS.

Development of the Disease

Currently, there are two theories behind the development of ALS, and both linked by the common factors. The first theory is that oxidative stress and mitochondrial dysfunction cause changes in RNA metabolism which ultimately causes motor neuron death. The second theory states that mutations in proteins that bind RNA cause oxidative stress, which eventually leads to mitochondrial dysfunction and causes motor neuron death. The common factors in these two theories being oxidative stress, mitochondrial dysfunction, and RNA mutations ultimately lead to the degeneration of motor neurons. However, these are just two theories. No one knows for sure what trigger is for the development of ALS.

Symptoms and Onset of ALS

Now that you know some of the science surrounding ALS, lets look at the symptoms associated with ALS.

Symptoms include but are not limited to,

  • Muscle weakness/loss/or atrophy
  • Muscle twitches (fasciculations)/cramps/or stiffness (spasticity)
  • Slurred and nasal speech
  • Difficulty chewing and swallowing
  • Excessive choking
  • Excessive shortness of breath
  • Hand or leg weakness
  • Problems with balance or walking
  • Fatigue

Onset of ALS typically occurs between the ages of 40 and 70, with the average age of diagnosis being 55. While the disease is more common among people age 60 and older, cases have been seen in people in their 20s and 30s. It has been shown that ALS is 20% more common in men than women, and a person’s risk percentage of developing ALS increases with age.

Once ALS starts, it continues to progress. Due to the fact there is no cure currently, most patients slowly lose the ability to walk, talk, swallow, and eventually breathe. The average survival time after diagnosis is 3 years, with 20% of those diagnosed living 5 or more years, 10% will live 10 years, and 5% will live 20 years.

What Can You Do?

Everyone has the power to help raise awareness for ALS, and there are many ways to do so. While scientists are busy working on finding a cure, we as society can rally together with events such as the Ice Bucket Challenge, and the ALS Walk to Defeat, among others.

Images:

Image 1: http://web.alsa.org/site/PageServer?pagename=WLK_BP_AboutALS#.XBAxLmhKjIU

Image 2: https://smw.ch/article/doi/smw.2015.14054/

Image 3: https://infograph.venngage.com/p/198726/ice-bucket-challenge-_new

More than the Ice Bucket Challenge

Have you ever met someone with amyotrophic lateral sclerosis, better known as ALS? Do you know anything about it besides that it was the origins and reasons behind the “Ice Bucket Challenge”?

In 2014 the Ice Bucket Challenge was sweeping the Nation, everyone from celebrities to average individuals were challenging their friends to do this to raise not only money but awareness of this disease. Popular news sources and celebrities doing it the summer of 2014 seems to be what truly brought ALS to the knowledge of the general public. Today they use the month of August to focus on ALS via media and sources like the Ice Bucket Challenge.

However, you may have done it and not truly known what it is or where it comes from. It seemed that many didn’t know and few did their own research into the topic. General consensus seemed along the lines of ‘it is a debilitating disease that eventually steals all mobility from someone until they die.’

So then what is it?

According to the ALS association it was originally discovered in 1869 by a French neurologist, but it wasn’t until 1939 when it got national recognition by the diagnosis of baseball player Lou Gehrig. It is still commonly known today as Lou Gehrig’s disease. ALS is a progressive neurodegenerative disease affecting the motor neurons in the brain and spinal cord leading to their eventual death and therefore loss of mobility and eventual paralysis (see picture on the right). Most of the patients end up passing due to respiratory distress or failure because of these neurons.

Most of the patients with ALS have a sporadic variation, sporadic ALS, rather than a genetic variation, or familial ALS. The familial ALS is exceedingly more rare than the sporadic. In the genetic variation, the age of onset is about 46, ten years younger than the sporadic form at 56. The only real difference between the two is the family history, otherwise they are clinically the same with mutations in the same gene. This gene is the SOD1 gene, responsible for generating the enzyme superoxide dismutase which breaks down oxidation. The SOD1 gene mutations causes a misfolding of proteins therefore unable to provide proper function.

So what happens when someone has ALS?

ALS develops in most people between the ages of 40 and 70, averaging around 55/56. It is 20% more common in men than women and your risk increases as you age. It will start with muscle weakness, progressively worsening, then atrophy or rigidity will likely start to occur. Basic tasks that require manual dexterity will become exceedingly difficult overtime. If it is initially affecting the legs it can lead to awkwardness when walking, tripping or stumbling more frequently. Some notice in their voice first with muscle spasms in the face and throat.

Because of some of these symptoms it is hard to differentiate between ALS and multiple sclerosis or MS in the beginning. Both are neuroinflammatory disorders that affect the muscles and ability to move the body due to attacks on the brain and spinal cord. MS however is more to do with the myelination surrounding the neurons.

Eventually people with ALS will sucumb to their disease either with respiratory failure/ distress or an additional illness they will not recover from. Some of the people with these illnesses actually die from morphine overdose in hospice facilities. It is not something commonly talked about but commonly is because the patient is given so much morphine to be kept comfortable that their organs start to shut down and they die.

The Neuroscience Behind It All:

Oxidation is a key component in ALS. Oxidative stress or damage is found to damage mitochondria, aggregate proteins, impair autophagy (cell death), and impair splicing proteins. Ultimately, this is a circular system between oxidative stress/ damage and FUS/ TDP4B. As stated prior oxidative stress leads to mitochondrial damage which in turn leads to the bad splicing of RNAs for the motor neurons. The Fus/TDP4B leads to oxidative stress and mitochondrial disfunction. TDP43 inhibits FOXO, a gene that tends to protect against oxidative damage, this causes a downregulation of mitochondrial proteins leading to oxidative damage. Mutations in the TDP43 gene changes the splicing location in Mtfr-1 which leads to mitochondrial fission. Lastly Fus activates PGC-1α which transcribes proteins, when Fus is not functioning correctly it can result in DNA damage, meaning more mutations. Overall this leads to problems.

ALS is a pretty scary condition for those whose lives are impacted by it. They are slowly losing themselves, becoming trapped inside their heads if they even last that long. This August join in with the Ice Bucket Challenge in helping to raise awareness and research funding for this terrible disease.

The Stresses of ALS

Image result for als

ALS, also known has Lou Gehrig’s disease, has become prevalent in modern media and news due to the diagnosis of Stephen Hawking, Stephen Hillenburg and other social figures. Amyotrophic Lateral Sclerosis (ALS) is a motor neuron degeneration disease that results in death, typically from respiratory failure. The motor neuron impairment is due to oxidative stress. This has been shown in many post-mortem studies, where ALS patients have an accumulation of oxidative damage to proteins, lipids and DNA. The key to understanding ALS is understanding motor neurons and why oxidative stress causes their degeneration and leads to the death of the individual.

Motor neurons are nerve cells that innervate muscles in order to pass an impulse from the brain or spinal cord. Messages from the brain are transmitted to motor neurons in the spinal cord and to motor nuclei of brain, then they go from the spinal cord and motor nuclei of brain to the particular muscle or muscles that are needed for the voluntary action. When someone has ALS, the neurons in the brain degenerate or die, which means they will stop sending messages to the muscles. The longer the muscles go without messages to function, they weaken and waste away. Eventually, there is no initiation or control of muscle movement. This is seen through symptoms of ALS such as muscle weakness, loss of ability to speak or eat, and eventually, the loss of the ability to breathe.Image result for als symptoms

Oxidative stress leads to the degeneration of these neurons through the presence of ROS. A significant proportion of ALS patients have a mutation for the gene encoding the enzyme SOD1. This enzyme is the defense against reactive oxygen species (ROS), which is produced during cellular metabolism and causes oxidative stress. So without the enzyme, ROS is produced and damages cell structures, such as motor neurons. This leads to the motor neuron issues previously described.

Unfortunately, there have not been any cures discovered for ALS, only treatments for symptoms. Ways to improve the quality of life for ALS patients include speech and physical therapies, along with medications to help reduce damage to motor neurons and to manage symptoms such as muscle cramps, stiffness, pain, depression and much more. The life expectancy of a person diagnosed with ALS is typically only 2 to 5 years after diagnosis.

Even though an ALS diagnosis is fatal, there is still a lot of research and support in the ALS community to fight this disease. While the scientific community is busy researching ways to cure ALS, communities are rallying with events such as the Ice Bucket Challenge, the ALS Walk to Defeat, and the One Dollar Difference platform to raise money to fight ALS.

Image result for als ice bucket challenge

 

Understanding ALS: Diagnostic Criteria and Early Warning Signs

https://www.medicalnewstoday.com/articles/321900.php

 

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects neurons in the central nervous system (CNS). There are two types of ALS; familial and sporadic, the latter being more common. The eventual death of the motor neurons causes the loss of voluntary movement. There is currently no cure for ALS and eventually progresses until death, typically occurring two to five years after initial diagnosis. Currently, there is little known about the disease in science and in the general public, it’s causes, and what to do from here. It is important to know the possible warnings signs of ALS and symptology to raise awareness about the possibility developing the disease.

Image 1: An infographic containing a range of information about ALS

Image source: http://www.alsa.org/news/public-awareness/als-awareness-month/2016/what-is-als.html

 

Early Signs and Risk Factors

Unfortunately the most common risk factors and warnings signs can be similar to symptoms, as ALS tends to be undetectable until the disease has progressed. Some of the easier warning signs that you could be developing ALS include:

  • Muscle weakness
  • Trouble projecting the voice
  • Difficulty swallowing
  • Inability to stop laughing or crying
  • Twitching of cramping of muscles

In addition to this, there are several risk factors that individuals should be aware of, especially when showing any of the symptoms listed above. Several risk factors that could predispose someone to ALS are:

  • Family history
  • Genetic factors and gene alterations
  • Smoking (a controversial claim)
  • Low intake of antioxidants and vitamin E
  • High physical fitness and low body mass index
  • Electrical occupations such as welding
  • Head trauma
  • Frontotemporal dementia

Despite what appears to be an overwhelming list, it is vital to know that there are certain environmental and genetic factors that may play a role in the development of ALS.

Image 2: Looking at the known risk factors that could lead to ALS and those that could be considered some but there remains further research into them to determine the validity of them.

Image source: https://fadavispt.mhmedical.com/Content.aspx?bookId=1895&sectionId=136495898

 

Symptoms

Some of the symptoms that are commonly present themselves in ALS, also seen in the early signs, are:

  • Difficulty with voluntary movement
  • Tripping and falling
  • Slurred speech
  • Difficulty holding head and keeping posture

The symptoms usually begin in the extremities and begin to affect the core as the disease progresses.  

 

How Physicians Diagnose ALS

Image 3: One of the ways that doctors diagnose ALS is by obtaining cerebrospinal fluid through a spinal tap, depicted in the image above. The need is inserted between vertebrae and draws the fluid out for testing.

Image source: https://www.cedars-sinai.org/health-library/diseases-and-conditions/a/amyotrophic-lateral-sclerosis-als.html

 

It is incredibly difficult to diagnose ALS, oftentimes the doctors must eliminate all other options before declaring a final diagnosis. ALS often mimics other neurological and neurodegenerative disease, which is the cause of the problem with diagnosis. There are test that exist that are able to rule out the other disease such as:

  • EMG
  • MRI
  • Blood and urine test
  • Spinal tap
  • Muscle biopsy

Once diagnosed, an individual should keep track of the progression of the disease, as it worsens over time. One of the difficult aspects of ALS as well is the fact that there are no completely effective treatments.  

 

Treatment and Therapies

There is no way to repair the damage that is done by ALS but there are treatments available that aim to slow the progression of the disease and lessen the severity of some of the other symptoms. There only two drugs that are currently approved by the FDA allowed to treat ALS itself. These are: Riluzole and Edaravone. Riluzole appears to slow the progression of ALS, perhaps by lowering the amount of glutamate in the brain. Edaravone, on the other hand, appears to lower the everyday cognitive decline that some patients experience during ALS. There are adverse side effects that are associated with both drugs.

Image 4: Doctors and researchers are working on new therapies and drugs to improve the quality of life as well as increasing life expectancy of those diagnosed with ALS.

Image source: https://www.israel21c.org/als-treatment-to-begin-phase-3-clinical-trials-in-us/

 

Some therapies exist such as breathing and speech therapies that aim to increase the quality of life. Social and psychological support groups also exist for those with ALS as well, as a resource for those to remember that they are not alone.

 

What to Remember

ALS is a complex disease that much more research needs to be conducted on to fully understand. The most important aspect of ALS is not necessarily the science but rather the people who experience the disease. The education of the public is so important so those with ALS to act as a support system and resource. Learn more about ALS and become and ally!

 

Sources:

http://www.alsa.org/about-als/what-is-als.html

https://blog.ochsner.org/articles/quick-guide-to-als-warning-signs

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334292/

https://www.mayoclinic.org/diseases-conditions/amyotrophic-lateral-sclerosis/diagnosis-treatment/drc-20354027 

ALS: The Real Story

Amyotrophic Lateral Sclerosis (ALS)

According to the Therapy Development Institute, ALS is defined as “a motor neuron disorder attacks certain cells in the brain and spinal cord needed to keep our muscles moving.” ALS doesn’t affect any of the five senses or cognitive functioning, making the disorder particularly devastating for the individual diagnosed and family. The average life-span of an individual after being diagnosed is 2-5 years. The disease affects many, with an overall lifetime risk of 1 in 400 to develop the disease.

How does ALS work? 

While not all the mechanisms of action of ALS are known, some of the main effectors in ALS are inflammation and oxidative stress that damages the mitochondrial functions. Other information on disease epidemiology is depicted in the image above.

SOD1 influence on ALS

Certain gene mutations have been associated with ALS, including on the SOD1 gene. SOD1 translates an enzyme with the function of converting superoxide (a harmful reactive oxygen species) into the less harmful H2O2. Mutated SOD1 genes lead to buildup of SOD1 aggregates which are not able to function, leading to an increase in oxidative stress.

Video Link: Some helpful information in understanding ALS!
https://www.youtube.com/watch?v=xrIjFVMliOQ

While it is important to look deeper at the mechanism of action for ALS and why it is particularly devastating, hearing individual testimonies on the disease offers a realistic view of the disorder. The following quotes come from individuals who are diagnosed with ALS or who have family members who have/have had the disorder.

I guess I never really knew the meaning of strength. Now I do.

I pray that all those who are suffering with this condition will one day be free from the pain of this most serious of experiences.

In three years he went from being perfectly healthy to not even being able to cluck a tongue and it all happened in the blink of an eye.

Unfortunately, she never came off that respirator and we spent the next five years watching her body deteriorate while she lived on life support. Her mind was sound and her will to live was strong, but we knew she was afraid of being alone and what was to come.

Sources

https://als-ny.org/blog/patients-families-tell-us-als-stories/

http://dmm.biologists.org/content/10/5/537

https://www.cell.com/trends/neurosciences/fulltext/S0166-2236(14)00085-X

 

 

 

How Can We Cure The Incurable?

Image result for als pictures

What is Amyotrophic Lateral Sclerosis (ALS)?

A progressive neurological degenerative disease of the upper (UMN) and lower motor neurons (LMN). Upper motor neurons in the brain send messages to the lower motor neurons in the spinal cord then to a group of muscles or a single muscle.  In ALS, UMN and LMN start to stop sending messages to the muscles. Furthering to symptoms of: muscular atrophy, muscle stiffness, slurred speech, and difficulty swallowing.

Most prevalent in males 55-75 in age. Most likely to develop in Non-Hispanics/Caucasians. Two different types of ALS:

  • Sporadic: 90% of cases with no clear risk factor or family history of the disease.
  • Familial: 10% of cases with inheritance of gene from at least one parent. 25-40% of familial is linked to defective C9orf72 gene. 12-20% of familial is linked to gene mutation in SOD1.

A factor in ALS is an untranslated region of C9orf72 gene linked to toxicity. *C9orf72 protein functions are still unclear. Research has also found SOD1 and TDP43 leads to unfolded protein aggregates found in motor neurons of ALS.

*More in depth scientific information

Treatment and Survival Rate

This disease is currently incurable. Treatments available are to help control the symptoms and making living with ALS easier.

Medication: Rilutek helps reduce damage to motor neurons by decreasing glutamate levels. Many medications that directly treat the symptoms such as muscle cramps, stiffness, depression, and constipation are usually prescribed. Edaravone, just FDA approved in 2017, is a known antioxidant to help with ALS.

Therapy: Physical therapy that use very low-impact exercises can help with cardiovascular health, fight fatigue, and strengthen the muscles that are still unaffected. Speech therapy to help with speaking and help improve or continue the ability to communicate.

Support: Nutritional support allows for increased ease of eating food as well as increased nourishment to continue calorie intake. With a high calorie intake, they will not lose weight as fast thus slowing down the progression of weakness. Breathing support such as a mask or other machines. This support is vital due to the weakness of the respiratory system is the common way of passing.

Unfortunately, this disease is very deadly. Most people die from respiratory failure within 3-5 of first symptoms being present. Rilutek has been found to slow down the progression and increase life expectancy by a few months.  Breathing support has also shown to prolong survival.

Rare Case: Stephen Hawking

A short video about Stephen Hawking published by the Washington Post.

Most people don’t survive 3-5 years after diagnosis of ALS; however, one man beat the odds and survived 55 years with ALS.

Stephen Hawking was a renounced theoretical physicist from Oxford, England. Throughout his life he had worked on the basic laws of the universe. His contribution to society had won him awards from Presidential Medal of Freedom to CBE. While accomplishing our further understanding of the universe, battled with ALS. At the age of 21 (1964), Stephen Hawking was diagnosed with ALS. Progressing over the years he became wheelchair-bound and used a computerized voice system. Even through the progression, he did not allow the disease to limit him. Stephen was a very rare and unique case.

Image result for als hope

Hope for a brighter future:

A discovery of the NEK-1 gene. The function of NEK1: maintaining neuron’s cytoskeleton and regulation of the membrane of mitochondria. This gene has been found to be in sporadic and familial ALS posing an opportunity for a new target for drug development for ALS. *Further research is being conducted.

Therapeutic target for C9orf72-associated ALS. A common gene mutation, C9orf72, is a genetic cause of ALS. Inhibition of Spt4 protein, was found to reduce toxicity caused by C9orf72 repeat expansion. *Further research is being conducted.

AstroRx, stem cell-gene therapy Clinical trials are recruiting after positive results in animal models with ALS. In hopes that using human embryonic stem cells to produce astrocyte progenitor cells in labs will be effective. Injecting healthy astrocytes into the spinal canal of mice had shown a delay of onset. *New Clinical Trial is being conducted.

*For more information on stem-cell research.

Image result for nurown

Positive results for NurOwn stem cell phase II trial. Mesenchymal stem cells from bone marrow are being used for cell therapy. Administered intramuscular and intrathecal injection showed to be safe and highly tolerated. *Research being continued into phase III.

*For more information on the trial

A better understanding of ALS has begun to emerge and more quickly since the Ice Bucket Challenge. This challenge has risen awareness as well as enough money to put toward research. Through the ALS foundation and remarkable researchers, a cure for the incurable is reachable in the near future.

References:

The ALS Association

National Institute of Neurological Disorders and Stroke

Stephen Hawking

 

 

 

Uncovering What We Don’t Know About ALS

Overview of ALS

Amyotrophic lateral sclerosis is a neurodegenerative disease that damages motor neurons of the central nervous system. This results in motor control problems and cognitive deficits that leave the person unable to live a normal life. Unfortunately, the only current treatments for this disease either slow symptom progression or reduce pain for end of life care. A more in depth understanding of the disease is necessary for developing a more permanent treatment option.

 

What we known about the disease

Two physiological processes play a role in the onset of ALS: oxidative stress and abnormal RNA metabolism. Oxidative stress occurs when too many free radicals exist within cells and cause too many oxidative reactions to occur. This can produce toxicity in the cell and eventual cell death. RNA dysmetabolism involves an issue with how RNA molecules are processed within the cell. Normally, RNA is cut up and spliced back together in a very specific way before it is utilized in the cell. With ALS, there is evidence that something does not work properly during this metabolism causing them to stick together and also creating cell toxicity. To complicate the story even further, there two processes have been shown to interact with each other resulting in a vicious cycle.

With a basic understanding of the pathology of the disease, it now makes sense why ALS progresses so quickly. Unlike other neurodegenerative diseases, which can take decades to fully develop, ALS can progress to a fatal stage within a couple years after diagnosis. People often begin to have problems moving their hands or arms and will quickly progress to have walking problems and end up in a wheel chair. Due to its damage to motor neurons, many people with ALS die of asphyxiation because their motor neurons controlling the diaphragm fail to function.

 

Why motor neurons?

An interesting characteristic of ALS is that, for the most part, it only affects motor neurons. While it is understood that oxidative stress and RNA problems contribute to the progression of the disease, it does not explain why specifically motor neurons are the only cells that become damaged. One theory is that since motor neurons require so much energy, they are the first cells to die when an imbalance occurs. Motor neurons are the longest cells in the body, as many of them in the spinal cord can reach up to a meter long. You can imagine if there is anything that messes with energy metabolism in the cell, it will quickly become ineffective and die.

More recent research has looked more closely into answering why motor neurons are particularly targeted in ALS. One study found that the problems associated with RNA metabolism could play an even larger role than previously thought. TAR DNA binding protein 43 (TPD43) is a protein that assists in the processing of RNA. It tells other enzymes where to cut and how to piece RNA back together. This protein has been shown to be useful in processing an RNA transcript coding for a survival motor neuron protein (SMN). Without SMN, the motor neuron is more vulnerable to death. Perhaps people with ALS have a deficiency in the TPD43 protein which causes less SMN to be produced contributing to motor neuron death.

 

Final thoughts

Although some is known about the pathophysiology of ALS, we have a long way to go before developing a cure. Even though the prevalence of ALS is not as high as similar neurodegenerative diseases, its rapid rate of progression sets it apart. Families dealing with ALS suffer a great deal by having to watch a loved one deteriorate and lose all ability to live their normal life. ALS can occur so quickly and unexpectedly that it can tear families apart. I hope in the future we will see progress in understanding this tragic disease and become better at treating it from the source.

 

 

Sources:

http://www.alsa.org/research/focus-areas/disease-mechanisms/

https://ghr.nlm.nih.gov/gene/SMN1

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661999/

https://www.123rf.com/clipart-vector/neurodegenerative_disease.html?sti=mluwnyxb2pzuijnu4p|

alspathways.com

 

ALS: the part that no one wants to talk about

ALS, often known as Lou Gehrig’s disease, is a debilitating and horrific disease. It is defined as amyotrophic lateral sclerosis and is a neurodegenerative disease that affects nerve cells in the brain and spinal cord. In short, ALS targets motor neurons in the brain and spinal cord which causes them to deteriorate and eventually die, leading to loss of control of voluntary muscle movement. This is the main reason why ALS is so debilitating is because people with this disease eventually lose their ability to eat, breathe, move, and speak independently.

What I found most peculiar about this disease is the varying amount of knowledge that common people in our society have. It’s different than cancer or other more common diseases that seem to be a typical topic of conversation surrounding disease. With ALS, it seems to be that if you have a family member or person in your life who has been affected by ALS, then you know a lot about the disease and the difficult effects it has on a family. But, if that is not the case, it seems as thought people do not know too much about the specifics of the disease. This is an odd observation because ALS has been brought into the spotlight through the great Stephen Hawking, through movies, and social media, like “Tuesdays with Morrie”, and the Ice Bucket Challenge video phenomenon. When it is an encouraging sign that ALS is at least being talked about, the part that no one wants to talk about if almost always overlooked: the end.

 

 

 

 

End of life care with ALS is difficult for a few reasons. First, there is no set structure or correct drug to use to help. This is because the progression of ALS can vary from being quickly deteriorating or drawn out over many months. The ALS Association as well as many palliative care sites suggest the discussion of end of life care beginning as soon as they feel comfortable after the loved one has been diagnosed. In addition, they suggest to start hospice when the person has six months or less to live if the disease progresses as it has been. This conversation is not an easy one to have, but is highly encouraged to have earlier on in the disease so that the loved one can have a say in treatment, care, etc.

An interesting study was done a few years back where they had 50 caregivers complete a survey about ALS patients’ last month of life. Some of the study’s findings are listed below:

  • Most common symptoms: difficulty communicating (62%), dyspnea (difficulty breathing) (56%), insomnia (42%), and discomfort other than pain (48%).
  • They reported an advance directive (medical treatment, living will, etc) was completed by 88% of patients
  • 2/3 of patients were enrolled in hospice
  • Compared to nonhospice patients, hospice patients were significantly more likely to
    • 1) die in their preferred location
    • 2) die outside the hospital
    • 3) receive morphine

This study is not the only of its kind. Many scientists, psychologists, and sociologists alike are looking into analyses and reviews like this one to collaborate on how to better the end of life care for people with hospice. The study did conclude with saying that “many patients with ALS still experience distressing physical symptoms in the last month of life, despite enrollment in hospice.” It is gravely difficult to create a comforting setting for someone in their last month of living with ALS. However, hospice is a great option to get as close to comfort as they can.

So, what’s next? I think that the topic of ALS can be brought up more in science classes in secondary education and in conversations about societal diseases. Getting into the details of what the disease actually is is an important way to begin discussion of how to help those suffering and those caring for their loved ones who suffer.

As put beautifully by Morrie Schwartz about his life…

“The truth is, once you learn how to die, you learn how to live.”

 

 

 

For more information:

http://www.alsa.org/about-als/facts-you-should-know.html

http://www.alsa.org/about-als/what-is-als.html

http://n.neurology.org/content/59/3/428

End of Life Options for ALS Patients

Amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s disease, is the loss of motor neurons in the brain which leads to a gradual loss in muscle control. The early symptoms of ALS vary but can include: a loss of dexterity in hands or fingers, tripping or stumbling more frequently than normal, changes to one’s voice, or facial muscle spasms with inappropriate laughing or crying. Once diagnosed, the function in one’s extremities and skeletal muscle will continue to deteriorate until complete paralysis. Most people with ALS die from respiratory failure within two to five years after diagnosis.

The most horrific part about ALS is that the person’s brain remains unaffected meaning that they are completely conscious of their deterioration even in the very late stages of the disease. This is especially hard for end of life cares when the affected individual no longer has the ability to communicate to their caregivers. The fascinating part about this disease is the fact that average onset occurs between the ages of 40 and 70 years old. Scientists are trying to uncover what factors change in the brain to cause the drastic deterioration of only motor neurons. While research still has a long way to go, they have identified some key components to ALS and how they can cause such devastating symptoms.

There are two heavily supported hypotheses for the science behind ALS. One emphasizes oxidative stress while the other highlights RNA dysmetabolism. Recent studies have been trying to combine these two theories with the dilemma of finding out which one comes first. Right now, we know that gene mutations in SOD1 and FUS result in a decreased protection from reactive oxygen species (ROS). ROS are dangerous chemicals that can disrupt cell function and eventually lead to cell death. Besides losing the original function of these genes, these mutations make the proteins easier to aggregate and clump together. The accumulation of non-functional proteins can then severely impair cell function and also lead to cell death. The million dollar question is why do these events only occur in motor neurons and not in other cells of the brain? Unfortunately, we do not know which means as of right now we do not have a cure for ALS.

Figure 1. Shows the many affects protein aggregation can have on a cell’s function.

With no cures, doctors can only focus on treating the symptoms of the disease. However, with ALS there are minimal options for the alleviation of symptoms except for pain tolerance. This leads to the daily regimen of opioids with a continual increase in dosage as patients become tolerant. Because of these increasing doses, many ALS patients actually die from morphine overdoses instead of natural causes. As bad as it seems, what other options do patients have to die painlessly? Currently, only 7 states offer physician-assisted suicide which gives patients the right to end their lives if they have been diagnosed with a terminal illness and have a life expectancy of 6 months or shorter.

While end of life decisions can be uncomfortable, they need to be discussed thoroughly and brought to the attention of every state government. Right now, what is the difference between physician-assisted suicide and the universal right to refuse lifesaving treatment such as CPR, chemotherapy, or blood transfusions? Also, Healthcare professions always emphasis that patients have the right to die with dignity, but what dignity does one have when their only wish was to die before the pain and torment of a disease like ALS. Honest discussions must be made to further our understanding and acceptance of such end of life options that many countries like Canada, Germany, and Finland have already legalized.

Spam prevention powered by Akismet